Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Medicenna Therapeutics Corp. is a clinical-stage immuno-oncology company focused on the development and commercialization of highly differentiated and proprietary Interleukin-2 (IL-2), Interleukin-4 (IL-4), and Interleukin-13 (IL-13) Superkines and first-in-class Empowered Cytokines™ (ECs) and Bi-functional SuperKine ImmunoTherapies (BiSKITs™). Their lead candidate, MDNA11, is an engineered long-acting IL-2 super-agonist designed to preferentially activate cancer-fighting immune cells. Medicenna aims to address unmet medical needs in the treatment of various cancers and other debilitating diseases.
Serves as the primary center for corporate management, strategic planning, research oversight, and administrative functions.
Located in a prominent commercial area of Toronto, offering access to a skilled workforce and a vibrant life sciences community. The office is likely modern and functional, designed to support a high-performance team.
As a clinical-stage biotech, the culture is likely dynamic, innovative, and mission-driven, with a strong emphasis on scientific rigor, collaboration, and achieving clinical milestones.
The Toronto headquarters places Medicenna within a leading North American biotech ecosystem, facilitating access to research institutions, capital markets, and industry talent.
While headquartered in Canada with a significant operational presence in the USA for clinical trials, Medicenna's reach is global through its research collaborations, participation in international scientific conferences, and its aim to develop therapies for patients worldwide. Their clinical trials may involve sites in multiple countries to ensure diverse patient populations and accelerate enrollment.
2 Bloor Street West, Suite 700
Toronto
Ontario
Canada
Address: Information not publicly listed, likely operates within a clinical research or biotech incubator space.
To facilitate and manage clinical development activities within the United States, tap into the U.S. talent pool for clinical research, and support business development in the region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Medicenna Therapeutics Corp.' leadership includes:
Medicenna Therapeutics Corp. has been backed by several prominent investors over the years, including:
In the past year, Medicenna Therapeutics Corp. has strengthened its financial leadership with a key appointment to support its ongoing clinical development and strategic growth.
Discover the tools Medicenna Therapeutics Corp. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Medicenna Therapeutics Corp. primarily utilizes the email format [first_initial][last_name]@medicenna.com. This is a common structure for companies in the biopharmaceutical industry.
flastname@medicenna.com
Format
fmerchant@medicenna.com
Example
85%
Success rate
Medicenna Therapeutics • March 25, 2024
Medicenna Therapeutics Corp. announced positive interim results from the monotherapy dose escalation arm of its Phase 1/2 ABILITY-1 study of MDNA11. The data showed durable anti-tumor activity and a favorable safety profile in heavily pre-treated patients with advanced solid tumors....more
Medicenna Therapeutics • February 13, 2024
Medicenna reported its financial results for the fiscal third quarter ended December 31, 2023, and provided updates on its clinical programs, including the ongoing MDNA11 ABILITY-1 study and preclinical development of its BiSKITs platform....more
Medicenna Therapeutics • September 20, 2023
Medicenna announced the appointment of Liz Williams as its new Chief Financial Officer. Ms. Williams brings over 20 years of financial leadership experience in the life sciences sector to Medicenna....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Medicenna Therapeutics Corp., are just a search away.